Gelteq Ltd cash flow statement

In fiscal 2025, Gelteq Ltd's operations generated −$3.6m of cash; it spent $2,019 on capital projects, leaving free cash flow of −$3.6m.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Gelteq Ltd: cash flow statement, annual
Fiscal year	2023Jun 2023	2025Jun 2025
Cash from operations	−1,192	−3,577
Depreciation and amortisation	826	792
Capital spending	23	2
Free cash flow	−1,215	−3,579

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: AKAN vs GELS GELS vs PRFX GELS vs SCNX

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Gelteq Ltd's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Gelteq Ltd.